USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.6.0

Summary

Query: Party Name contains all words: NOVARTIS AG
Number of results: 451+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

85586918
09/21/2012

Impax Laboratories, Inc.
Mark: RYTARY S#:85586918

Novartis AG
NOVARTIS CORPORATION

85588654
09/19/2012

goBlue International, LLC
Mark: GOBLUE S#:85588654

Novartis AG
Blue Cross and Blue Shield Association

85638848
09/19/2012

Alpha Helix Inc.
Mark: VOLTAGEN S#:85638848

Novartis AG

85561262
09/07/2012

Shisgal, Barry
Mark: MINERAL ICE S#:85561262

Novartis AG

91206628
08/20/2012

M&R of Fredericktown Limited, Inc.
Mark: NOVARIS S#:85469498

Novartis AG
Mark: NOVARTIS S#:75131409 R#:2336960
Mark: NOVARTIS S#:78365657 R#:2997235

85512166
07/24/2012

Clinial Therapeutic Solutions
Mark: KERA-42 CREAM S#:85512166

Novartis AG

85528483
07/19/2012

Novartis AG
Mark: LAMISIL S#:85528483

Blue Cross and Blue Shield Association

91206078
07/15/2012

Novartis AG
Mark: REVELLA S#:85417711

Forest Laboratories, Inc.
Mark: SAVELLA S#:77211766 R#:3658661
Mark: SAVELLA S#:77795756 R#:3761078

91206071
07/13/2012

Exelixis, Inc.
Mark: COMETRIX S#:85331887

Novartis AG
Mark: COMTREX S#:73087955 R#:1064290

85532091
07/11/2012

Novartis AG
Mark: RYLANAX S#:85532091

Biofarma

91205883
07/02/2012

Mylan Pharmaceuticals, Inc.
Mark: OYALAS S#:85388285

Novartis AG
Mark: ETHALAS S#:77963233

85510077
06/28/2012

Osmotica Holdings Corporation
Mark: SENORI S#:85510077

Novartis AG

85501837
06/21/2012

Novartis AG
Mark: ZIBRY S#:85501837

JPI Commercial, LLC

85375203
06/12/2012

Spartan Brands, Inc.
Mark: ALOE KERA S#:85375203

Novartis AG

85493040
06/11/2012

Teva Pharmaceutical Industries Ltd.
Mark: AZIDAY S#:85493040

Novartis AG

85493036
06/11/2012

Teva Pharmaceutical Industries Ltd.
Mark: AZIVIO S#:85493036

Novartis AG

85495819
06/01/2012

JOHNSON & JOHNSON
Mark: YUVELLE S#:85495819

Novartis AG

85485818
05/24/2012

GlaxoSmithKline Biologicals S.A.
Mark: MENSERIX S#:85485818

Novartis AG

85469498
05/21/2012

M&R of Fredericktown Limited, Inc.
Mark: NOVARIS S#:85469498

Texpon, Ltda.
Novartis AG

91204832
04/23/2012

ZO Skin Health, Inc.
Mark: ZO RX S#:85300593

Novartis AG
Mark: ZORTRESS S#:77912850 R#:3945609
Mark: ZORTRESS S#:79040925 R#:3379019

85331887
04/09/2012

Exelixis, Inc.
Mark: COMETRIX S#:85331887

Novartis AG
Iscotec AB
Glaxo Group Limited

91204609
04/05/2012

Novartis AG
Mark: OPHIDEL S#:85457567

Ares Trading S.A.
Mark: OVIDREL S#:77524655 R#:3604207

91204423
03/21/2012

Defiante Farmacêutica, S.A.
Mark: ONVERTIS S#:79094917

Novartis AG
Mark: NOVARTIS S#:75131409 R#:2336960
Mark: NOVARTIS S#:78365657 R#:2997235

85474968
03/22/2012

MVP Health Care, Inc.
Mark: GO MVP GENERATION GO S#:85474968

Novartis AG

85420810
03/22/2012

ADVENTRX Pharmaceuticals, Inc.
Mark: EXELBINE S#:85420810

Novartis AG